Calumet shares jump 10.14% intraday as HC Wainwright & Co. raises price target to $60 and BofA maintains $33 target, creating bullish consensus.

lunes, 30 de marzo de 2026, 9:57 am ET1 min de lectura
CLMT--
Calumet surged 10.14% intraday, driven by a bullish consensus as HC Wainwright & Co. maintained a buy rating and significantly raised its price target from $33 to $60, while BofA Securities also kept its buy rating with a $33 price target.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios